COST-EFFECTIVENESS OF A VIDEO-BASED EXERCISE PROGRAMME FOR FALLS PREVENTION AMONG OLDER ADULTS: A QUASI-EXPERIMENTAL STUDY
Author(s)
CHIZOBA F. IGWE, PhD1, Micheal O. Egwu, PhD2, Clara Fatoye, MA, PhD3, Tadesse Gebrye, MSc, MPH4, Chidozie Emmanuel Mbada, MA, PhD4, Ushotanefe Useh, MA, PhD4, Zalmai Hakimi, PharmD, PhD5, Francis Fatoye, MSc, PhD, MBA4.
1University of Lagos, Lagos, Nigeria, 2Obafemi Awolowo University, Ile-Ife, Nigeria, 3Global Banking School (GBS), Manchester, United Kingdom, 4Manchester Metropolitan University, Manchester, United Kingdom, 5Sobi, Amsterdam, Netherlands.
1University of Lagos, Lagos, Nigeria, 2Obafemi Awolowo University, Ile-Ife, Nigeria, 3Global Banking School (GBS), Manchester, United Kingdom, 4Manchester Metropolitan University, Manchester, United Kingdom, 5Sobi, Amsterdam, Netherlands.
OBJECTIVES: Telerehabilitation provides a feasible approach for falls prevention among older adults; however, evidence regarding its economic and broader health benefits remains limited. This study aimed to evaluate the cost-effectiveness of a Video-Based Exercise Programme (VBEP) compared with a Fall Risk Avoidance Education Pamphlet (FRAEP) in improving fall-related, functional, and psychosocial outcomes among older adults.
METHODS: A cost-effectiveness analysis was conducted alongside a quasi-experimental study. Participants were allocated to either the VBEP intervention group or the FRAEP wait-list control group. Outcomes were measured at baseline, week 4, and week 8. Health-related outcomes were assessed using the Short-Form Health Survey (SF-36), and quality-adjusted life years (QALYs) were estimated. The economic evaluation adopted a societal perspective, including both direct costs and indirect costs. Cost-effectiveness was expressed as incremental cost per life-year gained and incremental cost per QALY gained using the Incremental Cost Effectiveness Ratio (ICER).
RESULTS: Seventy participants were included, with 35 allocated to the VBEP group and 35 to the FRAEP group. The mean (SD) age was 71.74 (6.68) years in the VBEP group and 74.37 (7.99) years in the FRAEP group. Over the eight-week follow-up period, the VBEP achieved a mean incremental gain of 0.0113 QALYs per patient (95% CI: 0.0043-0.0184), equivalent to approximately 4.1 quality-adjusted life days. The total cost of delivering the VBEP was US$968.80, of which direct costs accounted for US$961.45. Compared with FRAEP, the VBEP incurred an additional cost of US$937.92 per patient, resulting in an ICER of US$83,001.77 per QALY gained.
CONCLUSIONS: The VBEP improved health-related outcomes among older adults and generated additional QALY gains compared with FRAEP alone. Although VBEP required higher upfront costs, it demonstrated measurable health benefits and may represent a cost-effective, scalable telerehabilitation approach for fall prevention, with the potential to reduce fall-related healthcare burden, enhance accessibility, and support healthy ageing.
METHODS: A cost-effectiveness analysis was conducted alongside a quasi-experimental study. Participants were allocated to either the VBEP intervention group or the FRAEP wait-list control group. Outcomes were measured at baseline, week 4, and week 8. Health-related outcomes were assessed using the Short-Form Health Survey (SF-36), and quality-adjusted life years (QALYs) were estimated. The economic evaluation adopted a societal perspective, including both direct costs and indirect costs. Cost-effectiveness was expressed as incremental cost per life-year gained and incremental cost per QALY gained using the Incremental Cost Effectiveness Ratio (ICER).
RESULTS: Seventy participants were included, with 35 allocated to the VBEP group and 35 to the FRAEP group. The mean (SD) age was 71.74 (6.68) years in the VBEP group and 74.37 (7.99) years in the FRAEP group. Over the eight-week follow-up period, the VBEP achieved a mean incremental gain of 0.0113 QALYs per patient (95% CI: 0.0043-0.0184), equivalent to approximately 4.1 quality-adjusted life days. The total cost of delivering the VBEP was US$968.80, of which direct costs accounted for US$961.45. Compared with FRAEP, the VBEP incurred an additional cost of US$937.92 per patient, resulting in an ICER of US$83,001.77 per QALY gained.
CONCLUSIONS: The VBEP improved health-related outcomes among older adults and generated additional QALY gains compared with FRAEP alone. Although VBEP required higher upfront costs, it demonstrated measurable health benefits and may represent a cost-effective, scalable telerehabilitation approach for fall prevention, with the potential to reduce fall-related healthcare burden, enhance accessibility, and support healthy ageing.
Conference/Value in Health Info
2026-11, ISPOR Europe 2026, Vienna, Austria
Value in Health, Volume 29, Issue 12S
Code
EE650
Topic
Economic Evaluation, Health Policy & Regulatory, Patient-Centered Research
Disease
Injury & Trauma, Musculoskeletal Disorders (Arthritis, Bone Disorders, Osteoporosis, Other Musculoskeletal)